Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients

Akshay Shetty, Adam Buch, Sammy Saab

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


As the demand for liver transplantation continues to rise, the scarcity of liver donor grafts has led to the use of extended criteria grafts for liver transplantation in select group of patients. Hepatitis C-seropositive liver grafts have been used primarily in hepatitis C-positive recipients, with studies showing non-inferior outcomes when compared to hepatitis C-negative grafts. Studies suggest that hepatitis C serology status of the donor liver does not influence the patient or graft outcomes in the recipient. These results advocate for offering hepatitis C-positive grafts to all patients awaiting liver transplantation regardless of their hepatitis C status. However, some concerns persist regarding the ethics of potentially introducing a new infection into a patient that could progress to chronic liver disease following liver transplantation. The recent approval of direct-acting antiviral therapy offers a solution to this dilemma, as it has changed the landscape of hepatitis C management by making it a curable disease. In this review, we shall discuss the current evidence regarding the use of hepatitis C-seropositive donor grafts in hepatitis C-positive and hepatitis C-negative patients.

Original languageEnglish (US)
Pages (from-to)1110-1118
Number of pages9
JournalDigestive Diseases and Sciences
Issue number5
StatePublished - May 15 2019


  • DAA, direct-acting antiviral
  • Donor grafts
  • Hepatitis C liver transplantation
  • Hepatitis C-positive donor grafts
  • Liver transplantation

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology


Dive into the research topics of 'Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients'. Together they form a unique fingerprint.

Cite this